These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 8907385)
1. Misoprostol with cyclosporin A prolongs corneal allograft survival in an animal model. Olsen TW; Gothard TW; Holland EJ Cornea; 1996 Jan; 15(1):76-81. PubMed ID: 8907385 [TBL] [Abstract][Full Text] [Related]
2. Flow-cytometric analysis of peripheral lymphocytes in the rat following penetrating keratoplasty and immunosuppressive treatment. Klebe S; Coupland SE; Krause L; Hoffmann F Ger J Ophthalmol; 1996 May; 5(3):137-45. PubMed ID: 8803575 [TBL] [Abstract][Full Text] [Related]
3. [Prolongation of corneal allograft survival in mice with a cyclosporine drug delivery system implant]. Shi W; Xie L; Wang S Zhonghua Yan Ke Za Zhi; 2002 Aug; 38(8):502-5. PubMed ID: 12410993 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of a topical cyclosporine A prodrug on corneal graft rejection in rats. Bourges JL; Lallemand F; Agla E; Besseghir K; Dumont JM; BenEzra D; Gurny R; Behar-Cohen F Mol Vis; 2006 Dec; 12():1461-6. PubMed ID: 17167400 [TBL] [Abstract][Full Text] [Related]
5. Immunosuppressive effect of misoprostol: a new synthetic prostaglandin E1 analogue. Wiederkehr JC; Dumble L; Pollak R; Moran M Aust N Z J Surg; 1990 Feb; 60(2):121-4. PubMed ID: 2109591 [TBL] [Abstract][Full Text] [Related]
6. [Experimental study on the effects of rapamycin in prevention of rat corneal allograft rejection]. Dong Y; Huang YF; Wang LQ; Chen B Zhonghua Yan Ke Za Zhi; 2005 Oct; 41(10):930-5. PubMed ID: 16271181 [TBL] [Abstract][Full Text] [Related]
7. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol. Siemionow MZ; Izycki DM; Zielinski M Transplantation; 2003 Dec; 76(12):1662-8. PubMed ID: 14688512 [TBL] [Abstract][Full Text] [Related]
8. Delay in corneal allograft rejection due to anti-CD4 antibody given alone and in combination with cyclosporin A and leflunomide. Coupland SE; Krause L; Karow AC; Bartlett RR; Lehmann M; Hoffmann F Ger J Ophthalmol; 1995 Sep; 4(5):294-301. PubMed ID: 7496341 [TBL] [Abstract][Full Text] [Related]
9. Alloantigen-pulsed host dendritic cells induce T-cell regulation and prolong allograft survival in a rat model of hindlimb allotransplantation. Kuo YR; Huang CW; Goto S; Wang CT; Hsu LW; Lin YC; Yang KD; Chen CL; Lee WP J Surg Res; 2009 May; 153(2):317-25. PubMed ID: 19101689 [TBL] [Abstract][Full Text] [Related]
10. 1 alpha,25-Dihydroxycholecalciferol reduces rejection and improves survival in rat liver allografts. Redaelli CA; Wagner M; Tien YH; Mazzucchelli L; Stahel PF; Schilling MK; Dufour JF Hepatology; 2001 Nov; 34(5):926-34. PubMed ID: 11679963 [TBL] [Abstract][Full Text] [Related]
11. [Efficacy of topical cyclosporine A on keratoplasty rejection in rats]. Zhang W; Pan Z; Zhai C Zhonghua Yan Ke Za Zhi; 2001 Mar; 37(2):140-3. PubMed ID: 11864411 [TBL] [Abstract][Full Text] [Related]
12. Trafficking of donor-derived bone marrow correlates with chimerism and extension of composite allograft survival across MHC barrier. Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Yoder B; Siemionow M Transplant Proc; 2006 Jun; 38(5):1625-33. PubMed ID: 16797371 [TBL] [Abstract][Full Text] [Related]
13. A novel immunomodulator KRP-203 combined with cyclosporine prolonged graft survival and abrogated transplant vasculopathy in rat heart allografts. Takahashi M; Shimizu H; Murakami T; Enosawa S; Suzuki C; Takeno Y; Hakamata Y; Kudou S; Izawa S; Yasue T; Kobayashi E Transplant Proc; 2005; 37(1):143-5. PubMed ID: 15808575 [TBL] [Abstract][Full Text] [Related]
14. The effect of A2A adenosine receptor agonist on composite tissue allotransplant survival: an in vivo preliminary study. Ulusal BG; Ulusal AE; Hung LM; Wei FC J Surg Res; 2006 Apr; 131(2):261-6. PubMed ID: 16457843 [TBL] [Abstract][Full Text] [Related]
15. Site-specific immunosuppression using a new formulation of topical cyclosporine A with polyethylene glycol-8 glyceryl caprylate/caprate. Tran HS; Malli D; Chrzanowski FA; Puc MM; Matthews MS; Hewitt CW J Surg Res; 1999 May; 83(2):136-40. PubMed ID: 10329107 [TBL] [Abstract][Full Text] [Related]
16. Penetrating keratoplasty in the rat: a model for the study of immunosuppressive treatment of graft rejection. Herbort CP; Matsubara M; Nishi M; Mochizuki M Jpn J Ophthalmol; 1989; 33(2):212-20. PubMed ID: 2474684 [TBL] [Abstract][Full Text] [Related]
17. [Experimental studies on the effect of the immunosuppressant FK-506 on penetrating keratoplasty rejection model in rats]. Lü L; Zhang W; Sun X Zhonghua Yan Ke Za Zhi; 1999 Jan; 35(1):25-8. PubMed ID: 11835769 [TBL] [Abstract][Full Text] [Related]
18. Lipopolysaccharide pretreatment of cyclosporine-treated rats enhances cardiac allograft survival. Lin H; Wei RQ; Bolling SF J Surg Res; 1993 Oct; 55(4):441-5. PubMed ID: 8412131 [TBL] [Abstract][Full Text] [Related]
19. Cyclosporine mitigates graft coronary artery disease in murine cardiac allografts: description and validation of a novel fully allogeneic model. Tanaka M; Mokhtari GK; Balsam LB; Cooke DT; Kofidis T; Zwierzchonievska M; Robbins RC J Heart Lung Transplant; 2005 Apr; 24(4):446-53. PubMed ID: 15797747 [TBL] [Abstract][Full Text] [Related]
20. Rejection following donor or recipient preoperative treatment with FTY720 in rat small bowel transplantation. Sakagawa T; Kiyochi H; Honda K; Kobayashi N Transpl Immunol; 2004 Nov; 13(3):161-8. PubMed ID: 15381198 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]